EUVIMEDEUVIMED entdecken
Crossref

Can TPS Expression Reliably Predict Treatment Outcomes and Survival in Nasopharyngeal Cancer?

Tuğba YILMAZ, Gül KANYILMAZ, Sıdıka FINDIK, Seda TAS AYÇİÇEK

Turkish Journal of Oncology · 2026 · 28-35

DOI: 10.5505/tjo.2026.4731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Oncology, 2026. Verfasst von Tuğba YILMAZ und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nasopharyngeal cancer (NPC) is highly treatment-sensitive, yet distant metastasis remains a challenge. Data on adjuvan therapy needs in non-metastatic (NM) cases from non-endemic regions (NERs) are limited. This retrospective cohort analysis aimed to evaluate the prognostic impact of PD-L1 and Tumor Proportion Score (TPS) in NM NPC patients from a NER.

Zitieren

APA

YILMAZ, T., KANYILMAZ, G., FINDIK, S., & AYÇİÇEK, S. T. (2026). Can TPS Expression Reliably Predict Treatment Outcomes and Survival in Nasopharyngeal Cancer?. Turkish Journal of Oncology, 28-35. https://doi.org/10.5505/tjo.2026.4731

Vancouver

YILMAZ T, KANYILMAZ G, FINDIK S, AYÇİÇEK ST. Can TPS Expression Reliably Predict Treatment Outcomes and Survival in Nasopharyngeal Cancer?. Turkish Journal of Oncology. 2026:28-35. doi:10.5505/tjo.2026.4731

BibTeX
@article{YILMAZ2026,
  author = {YILMAZ, Tuğba and KANYILMAZ, Gül and FINDIK, Sıdıka and AYÇİÇEK, Seda TAS},
  title = {Can TPS Expression Reliably Predict Treatment Outcomes and Survival in Nasopharyngeal Cancer?},
  journal = {Turkish Journal of Oncology},
  year = {2026},
  pages = {28--35},
  doi = {10.5505/tjo.2026.4731}
}
Kostenlos starten →